Search

Author/Creator Karlsson, Göril

1. Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial. (September 2022)

Authors:
Arnold, Douglas L; Piani-Meier, Daniela; Bar-Or, Amit; Benedict, Ralph HB; Cree, Bruce AC; Giovannoni, Gavin; Gold, Ralf; Vermersch, Patrick; Arnould, Sophie; Dahlke, Frank; Hach, Thomas; Ritter, Shannon; Karlsson, Göril; Kappos, Ludwig; Fox, Robert J
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 10(2022)
Page Start:
1526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses. (19th January 2021)

Authors:
Benedict, Ralph H.B.; Tomic, Davorka; Cree, Bruce A.; Fox, Robert; Giovannoni, Gavin; Bar-Or, Amit; Gold, Ralf; Vermersch, Patrick; Pohlmann, Harald; Wright, Ian; Karlsson, Göril; Dahlke, Frank; Wolf, Christian; Kappos, Ludwig
Journal:
Neurology
Issue:
Volume 96:Number 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis. (September 2021)

Authors:
Cree, Bruce AC; Magnusson, Baldur; Rouyrre, Nicolas; Fox, Robert J; Giovannoni, Gavin; Vermersch, Patrick; Bar-Or, Amit; Gold, Ralf; Piani Meier, Daniela; Karlsson, Göril; Tomic, Davorka; Wolf, Christian; Dahlke, Frank; Kappos, Ludwig
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 10(2021)
Page Start:
1564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search